针对9p21-缺陷质母细胞瘤中合成致命弱点的网络向组合疗法:一个案例报告
Michael P Castro1,2,3, Kristin Dittmar4
1Department of Oncology, Personalized Cancer Medicine, PLLC, Los Angeles, California, USA.
Neuro-oncology advances
|January 8, 2024
概括
这项研究强调了如何针对合成致命漏洞,如CDKN2A和MTAP在质母细胞瘤中的损失,可以导致患者显著的缓解. 这种方法为精准医学在治疗侵略性脑瘤方面提供了一个有希望的途径.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 质母细胞瘤复发和进展对救援疗法的反应有限.
- 综合的基因组分析识别了潜在的治疗点.
- 合成杀伤性利用瘤抑制基因损失来向癌细胞死亡.
研究的目的:
- 用于描述具有9p21染色体同胞性缺失的质母细胞瘤患者.
- 调查针对这个患者的合成致命漏洞的治疗潜力.
主要方法:
- 基因组分析,以确定瘤的脆弱性.
- 利用CDKN2A和MTAP损失相关的合成致命性.
- 佩米特雷克塞德,贝瓦齐祖马布和坎德沙坦的使用.
主要成果:
- 在患者身上实现了临床上有意义的缓解.
- 证明了多个合成致命节点的成功准.
- 在罕见的遗传背景下展示了组合治疗的有效性.
结论:
- 合成致死性可以解释特殊的治疗反应.
- 分子分析对于确定精准医学策略至关重要.
- 针对合成致命节点为质母细胞瘤治疗提供了一种有前途的方法.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527


